Alexandra V Yamshchikov

Summary

Publications

  1. doi request reprint Rhodococcus equi infection
    Alexandra V Yamshchikov
    Emory University School of Medicine, Division of Infectious Diseases, Decatur, GA 30030, USA
    Lancet Infect Dis 10:350-9. 2010
  2. pmc Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis
    Alexandra V Yamshchikov
    Department of Medicine, Emory University, Atlanta, GA, USA
    Am J Clin Nutr 92:603-11. 2010
  3. pmc Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report
    Alexandra V Yamshchikov
    Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA
    South Med J 102:649-52. 2009
  4. pmc Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis
    Leo Jeng
    Division of Endocrinology, Diabetes and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    J Transl Med 7:28. 2009
  5. pmc Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials
    Alexandra V Yamshchikov
    Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30030, USA
    Endocr Pract 15:438-49. 2009
  6. doi request reprint The role of vitamin D deficiency in sepsis and potential therapeutic implications
    Richard R Watkins
    Division of Infectious Diseases, Akron General Medical Center, Akron, OH 44302, USA
    J Infect 63:321-6. 2011

Detail Information

Publications6

  1. doi request reprint Rhodococcus equi infection
    Alexandra V Yamshchikov
    Emory University School of Medicine, Division of Infectious Diseases, Decatur, GA 30030, USA
    Lancet Infect Dis 10:350-9. 2010
    ..We review the pathogenesis and clinical characteristics of infections with Rhodococcus spp, and discuss approaches to treatment of this disease entity in populations of patients who are immunocompromised...
  2. pmc Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis
    Alexandra V Yamshchikov
    Department of Medicine, Emory University, Atlanta, GA, USA
    Am J Clin Nutr 92:603-11. 2010
    ..Little information is available on the clinical relation between vitamin D, LL-37 concentrations, and disease severity in patients with tuberculosis...
  3. pmc Vitamin D as adjunctive therapy in refractory pulmonary tuberculosis: a case report
    Alexandra V Yamshchikov
    Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA
    South Med J 102:649-52. 2009
    ..The basis for vitamin D/TB interactions and a brief literature review are discussed. Data from controlled trials are needed to evaluate the efficacy of vitamin D as adjunctive TB therapy...
  4. pmc Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis
    Leo Jeng
    Division of Endocrinology, Diabetes and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
    J Transl Med 7:28. 2009
    ..Thus, the relationship between vitamin D status and LL-37 production may be of importance for host immunity, but little data is available on this subject, especially in the setting of human sepsis syndrome and other critical illness...
  5. pmc Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials
    Alexandra V Yamshchikov
    Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30030, USA
    Endocr Pract 15:438-49. 2009
    ....
  6. doi request reprint The role of vitamin D deficiency in sepsis and potential therapeutic implications
    Richard R Watkins
    Division of Infectious Diseases, Akron General Medical Center, Akron, OH 44302, USA
    J Infect 63:321-6. 2011
    ..Further prospective, randomized, controlled clinical trials of adjunctive vitamin D therapy in patients who are deficient are needed in the management of human sepsis syndrome...